Application

16712261 · LIPOSOME FORMULATIONS

Filed 2019-12-12 · Granted · Patent 11712419 (2023-08-01) The official file ↗The patent and its PDF ↗ · Art unit 1612 · Examiner Snigdha Maewall Typical · CPC A61K 9/0048 · OPKO Pharmaceuticals, LLC · OPKO Health, Inc.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.0 mo

to disposition 43.6 mo

Statutes raised

101 103 112 DP

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.